| 10/06/2025 | UBS Group AG | 1101(L) | +8,701,500(L) | HKD 3.389(L) | 489,686,893(L) 472,184,151(S) | 13.02 12.55 | | 02/06/2025 | UBS Group AG | 1306(L) | 145,788,802(L) | | 478,230,055(L) 480,085,481(S) | 12.71 12.76 | | 30/05/2025 | UBS Group AG | 1305(L) | 12,660,880(L) | | 465,355,527(L) 465,433,024(S) | 12.37 12.37 | | 28/05/2025 | UBS Group AG | 1305(L) | 130,638,742(L) | | 468,190,302(L) 471,530,169(S) | 12.45 12.54 | | 27/05/2025 | UBS Group AG | 1402(S) | +24,838,597(S) | | 472,535,967(L) 475,354,334(S) | 12.56 12.64 | | 26/05/2025 | UBS Group AG | 1502(S) | -3,781,369(S) | | 463,519,141(L) 448,057,378(S) | 12.32 11.91 | | 23/05/2025 | UBS Group AG | 1306(L) | 129,973,185(L) | | 471,276,913(L) 456,359,150(S) | 12.53 12.13 | | 20/05/2025 | UBS Group AG | 1306(L) | 12,781,100(L) | | 462,166,213(L) 464,387,150(S) | 12.29 12.35 | | 19/05/2025 | UBS Group AG | 1305(L) | 148,944,620(L) | | 474,250,103(L) 465,440,150(S) | 12.61 12.37 | | 16/05/2025 | UBS Group AG | 1305(L) | 20,836,628(L) | | 463,523,580(L) 465,575,150(S) | 12.32 12.38 | | 15/05/2025 | UBS Group AG | 1306(L) | 158,785,020(L) | | 463,494,079(L) 465,703,150(S) | 12.32 12.38 | | 13/05/2025 | UBS Group AG | 1305(L) | 158,123,120(L) | | 484,289,585(L) 477,545,881(S) | 12.87 12.70 | | 12/05/2025 | UBS Group AG | 1306(L) | 150,951,776(L) | | 473,142,041(L) 473,871,381(S) | 12.58 12.60 | | 07/05/2025 | UBS Group AG | 1305(L) | 157,800,417(L) | | 469,676,353(L) 473,027,881(S) | 12.49 12.57 | | 05/05/2025 | UBS Group AG | 1306(L) | 157,192,708(L) | | 468,837,056(L) 472,524,381(S) | 12.46 12.56 | | 28/04/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1101(L) | +2,000,000(L) | HKD 1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 | | 28/04/2025 | LuYe Pharmaceutical International Co., Ltd. | 1101(L) | +2,000,000(L) | HKD 1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 | | 28/04/2025 | Luye Pharma Holdings Ltd. | 1101(L) | +2,000,000(L) | HKD 1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 | | 28/04/2025 | Luye Life Sciences Group Ltd | 1101(L) | +2,000,000(L) | HKD 1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 | | 28/04/2025 | Nelumbo Investments Limited | 1101(L) | +2,000,000(L) | HKD 1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 | | 28/04/2025 | Ginkgo (PTC) Limited | 1101(L) | +2,000,000(L) | HKD 1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 | | 28/04/2025 | Shorea LBG | 1101(L) | +2,000,000(L) | HKD 1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 | | 28/04/2025 | 刘殿波 | 1314(L) | +2,000,000(L) | | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 | | 22/04/2025 | Luye Life Sciences Group Ltd | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 22/04/2025 | Nelumbo Investments Limited | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 22/04/2025 | Ginkgo (PTC) Limited | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 22/04/2025 | 刘殿波 | 1314(L) | 17,088,000(L) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 22/04/2025 | LuYe Pharmaceutical International Co., Ltd. | 1314(L) | 17,088,000(L) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 22/04/2025 | Nelumbo Investments Limited | 1314(L) | 17,088,000(L) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 22/04/2025 | Luye Pharma Holdings Ltd. | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 22/04/2025 | Luye Life Sciences Group Ltd | 1314(L) | 17,088,000(L) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 22/04/2025 | Shorea LBG | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 22/04/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1314(L) | 17,088,000(L) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 22/04/2025 | LuYe Pharmaceutical International Co., Ltd. | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 22/04/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 22/04/2025 | Shorea LBG | 1314(L) | 17,088,000(L) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 22/04/2025 | Luye Pharma Holdings Ltd. | 1314(L) | 17,088,000(L) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 22/04/2025 | 刘殿波 | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 22/04/2025 | Ginkgo (PTC) Limited | 1314(L) | 17,088,000(L) | | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | | 21/04/2025 | UBS Group AG | 1305(L) | 13,369,550(L) | | 465,328,456(L) 464,873,640(S) | 12.37 12.36 | | | 1 2 3 4 5 6 7 8 9 |
|